Still Hungry on Mounjaro 2.5mg: How Long Does the Appetite Effect Take?

What the trial data say about appetite at the starter dose

The SURMOUNT-1 trial, published in the New England Journal of Medicine, enrolled 2,539 adults and ran for 72 weeks. Participants titrated through doses over time, and the most significant weight reductions (averaging around 20–21% of body weight at 15mg) accumulated across many months, not weeks. At the 2.5mg starting level, weight change was modest at best. This was by design: the starter pen's job is to reduce the chance of nausea, not to treat the underlying condition. Researchers and prescribers have consistently described 2.5mg as a tolerability step, which is why the licensed schedule moves on after four weeks regardless of how much appetite suppression you feel.

If you are reading this because you are still hungry on Mounjaro 2.5mg and wondering how long it takes to feel anything, that frustration is completely understandable. You have started a treatment, you are doing everything right, and your body is not giving you much feedback yet. That is a very common experience at this stage, and it does not mean the medicine is wrong for you.

The practical upshot from the evidence: hunger reduction is dose-dependent with tirzepatide. The further you titrate, the more pronounced the effect tends to be, both in terms of how full you feel between meals and how quickly you feel full during them. Four weeks at 2.5mg is the gateway, not the destination. Our overview of tirzepatide for weight management covers how the full titration schedule works in more detail.

Why appetite suppression takes longer to settle in than people expect

Tirzepatide activates both the GIP and GLP-1 receptors, which are involved in signalling fullness and slowing how quickly the stomach empties. These effects are real and well-established, but they are not instant, and they are not linear. After each dose increase, it generally takes one to two weeks for the new level to reach a steady concentration in the body and for appetite-related changes to become noticeable. Some people feel a distinct shift within days of moving from 2.5mg to 5mg; others need closer to two weeks at the new dose before they register a clear difference in hunger levels.

There is also a learning curve with appetite cues. People who have lived with persistent hunger for years sometimes describe difficulty distinguishing between genuine physiological hunger and habitual eating patterns, particularly in the first weeks of treatment. That distinction often becomes clearer as the dose rises. For context on how the hunger picture can change at the next dose step, it is worth reading about what people commonly experience moving to 5mg.

None of this means you should sit and wait passively. Protein adequacy, staying hydrated and not skipping meals entirely all support how well the medicine can work alongside titration. Your prescriber or our aftercare team are the right people to speak to if you have specific questions about your plan at this stage.

When staying hungry on 2.5mg might be worth flagging

In most cases, persistent hunger at 2.5mg is normal and self-resolving once the dose increases. There are, however, situations where it is worth getting in touch with your prescribing team sooner rather than later. If you are experiencing significant nausea or vomiting at 2.5mg that is making it hard to eat at all, that is different from hunger and should be discussed. If you are unsure whether your dose increase is on schedule, or if circumstances have changed that might affect your treatment plan, those conversations belong with your prescriber. You can find our aftercare team via the contact page, seven days a week.

It is also worth knowing that hunger patterns can vary beyond just dose. Sleep quality, stress levels and certain medications can all affect appetite signals independently of tirzepatide. If you are moving toward higher doses and still finding hunger levels are not shifting even at 12.5mg, that is a useful piece of information for your prescriber, not a reason to stop. The experience at 15mg is notably different from the starter dose, and for most people the trajectory between 2.5mg and that maintenance level shows consistent improvement.

For anyone thinking ahead to the wider picture (what treatment costs, how the programme works, or whether this is the right route) the cost and service context page sets out what is included clearly. And if you are still exploring whether to begin, starting a free consultation is the first practical step toward finding out whether tirzepatide is appropriate for you.